Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis von Richeldi, Luca, Azuma, Arata, Cottin, Vincent, Hesslinger, Christian, Stowasser, Susanne, Valenzuela, Claudia, Wijsenbeek, Marlies S., Zoz, Donald F., Voss, Florian, Maher, Toby M.

Volltext

Gradient dynamics approach to reactive thin-film hydrodynamics von Voss, Florian, Thiele, Uwe

Volltext

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial von Rabe, Klaus F, Halpin, David M G, Han, MeiLan K, Miravitlles, Marc, Singh, Dave, Grönke, Lars, Voß, Florian, Martinez, Fernando J

Volltext

A Setup for Camera-Based Detection of Simulated Pathological States Using a Neonatal Phantom von Voss, Florian, Lyra, Simon, Blase, Daniel, Leonhardt, Steffen, Lüken, Markus

Volltext

β-Blockers in COPD: A Cohort Study From the TONADO Research Program von Maltais, François, Buhl, Roland, Koch, Andrea, Amatto, Valeria C, Reid, Jim, Grönke, Lars, Bothner, Ulrich, Voß, Florian, McGarvey, Lorcan, Ferguson, Gary T

Volltext

Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials von Ferguson, Gary T., Buhl, Roland, Bothner, Ulrich, Hoz, Alberto de la, Voß, Florian, Anzueto, Antonio, Calverley, Peter M.A.

Volltext

Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease von Buhl, Roland, Magder, Sheldon, Bothner, Ulrich, Tetzlaff, Kay, Voß, Florian, Loaiza, Lazaro, Vogelmeier, Claus F, McGarvey, Lorcan

Volltext

Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies von Singh, Dave, Gaga, Mina, Schmidt, Olaf, Bjermer, Leif, Grönke, Lars, Voß, Florian, Ferguson, Gary T

Volltext

Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis von Schlueter, Max, Gonzalez-Rojas, N, Baldwin, Michael, Groenke, Lars, Voss, Florian, Reason, Tim

Volltext

Multi-modal body part segmentation of infants using deep learning von Voss, Florian, Brechmann, Noah, Lyra, Simon, Rixen, Jöran, Leonhardt, Steffen, Hoog Antink, Christoph

Volltext

Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD von Maltais, François, Hamilton, Alan, Voß, Florian, Maleki-Yazdi, M. Reza

Volltext

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risks von Stegherr, Regina, Schmoor, Claudia, Beyersmann, Jan, Rufibach, Kaspar, Jehl, Valentine, Brückner, Andreas, Eisele, Lewin, Künzel, Thomas, Kupas, Katrin, Langer, Frank, Leverkus, Friedhelm, Loos, Anja, Norenberg, Christiane, Voss, Florian, Friede, Tim

Volltext

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies von Ferguson, Gary T., Karpel, Jill, Bennett, Nathan, Clerisme-Beaty, Emmanuelle, Grönke, Lars, Voß, Florian, Buhl, Roland

Volltext

Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies von Maltais, François, Kirsten, Anne-Marie, Hamilton, Alan, De Sousa, Dorothy, Voß, Florian, Decramer, Marc

Volltext

The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies von Ichinose, Masakazu, Taniguchi, Hiroyuki, Takizawa, Ayako, Grönke, Lars, Loaiza, Lazaro, Voß, Florian, Zhao, Yihua, Fukuchi, Yoshinosuke

Volltext

Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial von Assassi, Shervin, Distler, Oliver, Allanore, Yannick, Ogura, Takashi, Varga, John, Vettori, Serena, Crestani, Bruno, Voss, Florian, Alves, Margarida, Stowasser, Susanne, Maher, Toby M.

Volltext

Plain language summary: clinical trial of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis von Luca Richeldi, Arata Azuma, Vincent Cottin, Christian Hesslinger, Susanne Stowasser, Claudia Valenzuela, Marlies S Wijsenbeek, Donald F Zoz, Florian Voss, Toby M Maher

Volltext

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD) von Maher, Toby M, Assassi, Shervin, Azuma, Arata, Cottin, Vincent, Hoffmann-Vold, Anna-Maria, Kreuter, Michael, Oldham, Justin M, Richeldi, Luca, Valenzuela, Claudia, Wijsenbeek, Marlies S, Coeck, Carl, Schlecker, Christina, Voss, Florian, Wachtlin, Daniel, Martinez, Fernando J

Volltext

Effects of baseline symptom burden on treatment response in COPD von Martinez, Fernando J, Abrahams, Roger A, Ferguson, Gary T, Bjermer, Leif, Grönke, Lars, Voß, Florian, Singh, Dave

Volltext

Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease von Deterding, Robin, Griese, Matthias, Deutsch, Gail, Warburton, David, DeBoer, Emily M., Cunningham, Steven, Clement, Annick, Schwerk, Nicolaus, Flaherty, Kevin R., Brown, Kevin K., Voss, Florian, Schmid, Ulrike, Schlenker-Herceg, Rozsa, Verri, Daniela, Dumistracel, Mihaela, Schiwek, Marilisa, Stowasser, Susanne, Tetzlaff, Kay, Clerisme-Beaty, Emmanuelle, Young, Lisa R.

Volltext